Home
Scholarly Works
Greater reduction in hard exudates with faricimab...
Conference

Greater reduction in hard exudates with faricimab vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE/RHINE trials

Authors

Goldberg RA; Amador M; Dinah C; Gibson K; Glittenberg CGO; Maunz A; O'Leary O; Rahimy E; Uschner D

Volume

65

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Publication Date

June 1, 2024

Name of conference

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Conference place

WA, Seattle

Conference start date

May 5, 2024

Conference end date

May 9, 2024

Conference proceedings

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Issue

7

ISSN

0146-0404

Labels

Fields of Research (FoR)

Contact the Experts team